46-60 of 259
Evaluating Gene Therapy for Sickle Cell Disease: Advantages and Barriers
Project Oncology®Evaluating Gene Therapy for Sickle Cell Disease: Advantages and Barriers
David Jacobsohn
GeneHarmony: Mapping Shared Genes in Autoimmune Disease
Living RheumGeneHarmony: Mapping Shared Genes in Autoimmune Disease
Curative Strategies for Sickle Cell Disease: The Future of Gene Editing
Project Oncology®Curative Strategies for Sickle Cell Disease: The Future of Gene Editing
Alexis Leonard
Genetic Testing in Pediatrics: Identifying Neurodevelopmental Disorders Early
Clinician's RoundtableGenetic Testing in Pediatrics: Identifying Neurodevelopmental Disorders Early
Jennifer M. Kalish, MD, PhD, FAAP
Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant
NeuroFrontiersGenetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant
Sergio Baranzini, PhD
Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers
Project Oncology®Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers
Paola Marignani, PhD, EMBA
- advertisement
Unlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
Project Oncology®Unlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
Paola Marignani, PhD, EMBA
Targeting CCR4 in CAR-Associated Peripheral T-Cell Lymphoma
Project Oncology®Targeting CCR4 in CAR-Associated Peripheral T-Cell Lymphoma
Advances in Alzheimer’s Diagnosis: From Imaging to Artificial Intelligence
NeuroFrontiersAdvances in Alzheimer’s Diagnosis: From Imaging to Artificial Intelligence
Marc Haut, PhD
Transforming Alzheimer’s Care: Anti-Amyloid Therapies and Emerging Genetic Approaches
NeuroFrontiersTransforming Alzheimer’s Care: Anti-Amyloid Therapies and Emerging Genetic Approaches
Marc Haut, PhD
Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Project Oncology®Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Epigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
NeuroFrontiersEpigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
David Gate, PhD
- advertisement
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
NeuroFrontiersASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
Safety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
NeuroFrontiersSafety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
New-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
NeuroFrontiersNew-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
